Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Xiao Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6463-5628; OpenAlex author ID A5101577217. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery. Last author DOI 10.1080/02656736.2024.2398557↗
  2. Ferroptosis-Related IncRNAs Are Prognostic Biomarker of Overall Survival in Pancreatic Cancer Patients. Last author DOI 10.3389/fcell.2022.819724↗
  3. Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.698296↗
  4. NR2F1-AS1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Competing Endogenous RNA Regulatory Network Constructed by Sponging miRNA-146a-5p/miRNA… Last author DOI 10.3389/fcell.2021.736980↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yunfei Liu · 2 shared papers, 2021–2024 · strength 0.40
  2. Hongwei Zhu · 2 shared papers, 2021–2022 · strength 0.35
  3. Guangping Tu · 1 shared paper, 2024 · strength 0.23
  4. Li Yu · 1 shared paper, 2024 · strength 0.23
  5. Qiuling Shi · 1 shared paper, 2024 · strength 0.23
  6. Longjun Zang · 1 shared paper, 2022 · strength 0.17
  7. Dongjie Chen · 1 shared paper, 2022 · strength 0.17
  8. Wenzhe Gao · 1 shared paper, 2022 · strength 0.17
  9. Dong Luo · 1 shared paper, 2021 · strength 0.17
  10. Wenzhi Guo · 1 shared paper, 2021 · strength 0.15
  11. Qingyuan Zheng · 1 shared paper, 2021 · strength 0.15
  12. Qiyao Zhang · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.